🔎 Trials Near Me

Domov › Rak pljuč › Connecticut › New Haven

Klinične študije za Rak pljuč v New Haven, CT

22 študij za Rak pljuč išče udeležence na lokacijah v New Haven in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3
  • Yale University, New Haven
  • Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi stran
  • Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi stran
  • in še 2
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Vključevanje udeležencevFaza 1/2
  • Yale Cancer Center, New Haven
Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 2
  • Yale Cancer Center, New Haven
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Vključevanje udeležencevFaza 3
  • Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi stran
Starost 70 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Vključevanje udeležencevFaza 3
  • Yale University, New Haven
  • Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi stran
  • Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi stran
  • in še 1
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT04181060

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Vključevanje udeležencevFaza 3
  • Yale University, Smillow Cancer Center, New Haven
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06881784

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • Smilow Cancer Hospital - Yale New Haven Health, New Haven
  • Yale - New Haven Hospital - Yale Cancer Center, New Haven
  • Smilow Cancer Hospital Phase 1 Unit, New Haven
  • in še 1
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07519655

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 2
  • Research Site, New Haven
Starost 18–95 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05061550

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Vključevanje udeležencevFaza 1
  • Yale Cancer Center, New Haven
Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07349537

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Vključevanje udeležencevFaza 1/2
  • Yale University, New Haven
  • Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06287775

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Vključevanje udeležencevFaza 1/2
  • Yale University School of Medicine - Yale Cancer Center, New Haven
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT05786924

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Yale University School of Medicine, New Haven
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Vključevanje udeležencevFaza 1/2
  • Avenzo Therapeutics Recruiting Site, New Haven
Starost 18–75 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07038343

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 1
  • Yale Cancer Center, New Haven
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06343402

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Vključevanje udeležencevFaza 1
  • Xencor Investigative Site, New Haven
Starost 18 in več · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT05433142

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Vključevanje udeležencevFaza 1/2
  • Yale University Cancer Center, New Haven
Starost 18 in več · Vsi spoli · Posodobljeno 15. jul. 2026 · NCT05652686

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Yale University, New Haven
  • Smilow Cancer Hospital-Orange Care Center, Orange · 5 mi stran
  • Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi stran
  • in še 2
Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05642572

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Vključevanje udeležencevFaza 1
  • Smilow Cancer Hospital (Yale University), New Haven
Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT06040541

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Yale University, New Haven
  • Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi stran
  • Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi stran
  • in še 1
18 Minutes · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2/3
  • Yale University, New Haven
  • Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi stran
  • Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi stran
  • in še 1
Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • Yale New Haven Medical Center, New Haven
Starost 18 in več · Vsi spoli · Posodobljeno 5. mar. 2026 · NCT06196008

The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)

Vključevanje udeležencevOpazovalna študija
  • Yale School of Medicine, New Haven
Starost 18–99 · Vsi spoli · Posodobljeno 12. avg. 2025 · NCT06412172

Študije za Rak pljuč v drugih mestih

Druge študije v New Haven

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.